Live
- They always want me to win, and now I feel lucky to have been offered a story like ‘Zebra’: Satyadev Kancharana
- ‘Democracy first, humanity first’: PM Modi in Guyana's parliament on two countries' similarities
- PKL Season 11: Telugu Titans register third straight win to top standings
- Is Pollution Contributing to Your COPD?
- NASA Unveils Underwater Robots for Exploring Jupiter's Moons
- Additional Central forces arrive in violence-hit Manipur
- AR Rahman and Saira Banu’s Divorce: Legal Insights into Common Issues in Bollywood Marriages
- 82.7 pc work completed in HPCL Rajasthan Refinery area: official
- Curfew relaxation extended in 5 Manipur districts on Friday
- Tab scam prompts Bengal govt to adopt caution over fund disbursement
ICMR bats for Oxford vaccine
The Indian Council of Medical Research (ICMR) on Sunday said that a candidate vaccine called ChAdOX1 a" being developed by researchers at University of Oxford
New Delhi: The Indian Council of Medical Research (ICMR) on Sunday said that a candidate vaccine called ChAdOX1 a" being developed by researchers at University of Oxford -- is the frontrunner in the race to take on the deadly COVID-19 virus which has infected over 23 lakh people globally, killing over 1.60 lakh people.
Speaking at a daily media briefing in the Capital, Dr Raman Gangakhedkar who is the chief scientist of ICMR said that at least 70 groups of scientists across the world have been working towards a novel coronavirus vaccine and five groups have come into human trial phase -- with ChAdOx1 leading the race.
On Friday, scientists at the University of Oxford promised a super-fast vaccine during a virtual press conference, saying it would be available by September.
According to lead researcher Professor Sarah Gilbert, their ChAdOx1 vaccine can work against the virus called SARS-CoV-2.
